Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,611 | 340 | 89.6% |
| Honoraria | $300.00 | 1 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $295.00 | 2 | 4.0% |
| Consulting Fee | $150.00 | 1 | 2.0% |
| Education | $18.91 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,114 | 56 | $0 (2022) |
| Janssen Biotech, Inc. | $933.64 | 50 | $0 (2024) |
| GENZYME CORPORATION | $406.69 | 7 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $322.16 | 26 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $305.39 | 20 | $0 (2024) |
| Advanced Respiratory, Inc | $300.00 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $287.93 | 13 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $270.59 | 15 | $0 (2020) |
| Ardelyx, Inc. | $268.74 | 20 | $0 (2023) |
| QOL Medical, LLC | $263.84 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $880.34 | 37 | Janssen Biotech, Inc. ($360.78) |
| 2023 | $1,083 | 66 | Janssen Biotech, Inc. ($358.20) |
| 2022 | $1,295 | 72 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($284.53) |
| 2021 | $104.38 | 4 | Amgen Inc. ($52.84) |
| 2020 | $1,173 | 46 | Amgen Inc. ($366.90) |
| 2019 | $1,131 | 54 | Amgen Inc. ($373.95) |
| 2018 | $1,001 | 45 | Amgen Inc. ($165.52) |
| 2017 | $707.52 | 21 | GENZYME CORPORATION ($250.00) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Immunology | ||||||
| 11/14/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: GI | ||||||
| 11/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Immunology | ||||||
| 09/28/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Immunology | ||||||
| 07/26/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Rare Disease | ||||||
| 07/01/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Immunology | ||||||
| 06/28/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Rare Disease | ||||||
| 06/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Immunology | ||||||
| 06/07/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/24/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Immunology | ||||||
| 05/20/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Hepatology / Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 141 | 445 | $63,290 | $27,840 |
| 2022 | 6 | 95 | 278 | $38,002 | $16,685 |
| 2021 | 4 | 61 | 182 | $26,248 | $11,406 |
| 2020 | 5 | 79 | 282 | $38,629 | $14,408 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 209 | $34,694 | $15,255 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 95 | $22,800 | $9,684 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $3,900 | $2,105 | 54.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 27 | $1,080 | $278.52 | 25.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 42 | $252.00 | $246.96 | 98.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 21 | 45 | $360.00 | $177.30 | 49.3% |
| 83014 | Administration of drug for helicobacter pylori | Office | 2023 | 12 | 12 | $204.00 | $92.40 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 170 | $28,220 | $11,944 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 31 | $7,440 | $3,113 | 41.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,050 | $956.28 | 91.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $420.00 | $412.20 | 98.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 17 | $680.00 | $164.32 | 24.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 19 | 32 | $192.00 | $95.01 | 49.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 137 | $22,742 | $9,598 | 42.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $2,860 | $1,613 | 56.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 13 | $520.00 | $132.38 | 25.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 13 | 21 | $126.00 | $63.00 | 50.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 207 | $34,362 | $11,990 | 34.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $2,860 | $1,414 | 49.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $825.00 | $670.78 | 81.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $330.00 | $208.56 | 63.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 20 | 42 | $252.00 | $125.52 | 49.8% |
About Dr. Sabena Toor, MD
Dr. Sabena Toor, MD is a Pulmonary Disease healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013097088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sabena Toor, MD has received a total of $7,375 in payments from pharmaceutical and medical device companies, with $880.34 received in 2024. These payments were reported across 345 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($6,611).
As a Medicare-enrolled provider, Toor has provided services to 376 Medicare beneficiaries, totaling 1,187 services with total Medicare billing of $70,339. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Los Angeles, CA
- Active Since 10/16/2006
- Last Updated 09/15/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1013097088
Products in Payments
- STELARA (Biological) $809.98
- Repatha (Biological) $481.26
- ZERBAXA (Drug) $307.95
- Life 2000 Ventilation System (Device) $300.00
- IBSRELA (Drug) $268.74
- XIFAXAN (Drug) $260.70
- NIEMANN-PICK B (Drug) $250.00
- SHINGRIX (Biological) $248.31
- DUPIXENT (Biological) $233.30
- Veltassa (Drug) $229.11
- EVENITY (Biological) $195.62
- SUCRAID (Drug) $195.01
- ENTYVIO (Biological) $187.40
- JYNARQUE (Drug) $182.34
- Rayaldee (Drug) $166.87
- ACTHAR (Biological) $152.68
- Talicia (Drug) $148.81
- Parsabiv (Biological) $143.18
- GATTEX (Drug) $136.63
- Prolia (Biological) $130.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Los Angeles
Prof. Toby Maher, Md, MD
Pulmonary Disease — Payments: $1.1M
Donald Tashkin, Md, MD
Pulmonary Disease — Payments: $646,650
Rajan Saggar, Md, MD
Pulmonary Disease — Payments: $426,392
John Belperio, Md, MD
Pulmonary Disease — Payments: $308,808
Christopher Cooper, Md, MD
Pulmonary Disease — Payments: $207,817
Robert Strieter, Md, MD
Pulmonary Disease — Payments: $172,942